TITLE

Metabolic syndrome in Thai schizophrenic patients: a naturalistic one-year follow-up study

AUTHOR(S)
Srisurapanont, Manit; Likhitsathian, Surinporn; Boonyanaruthee, Vudhichai; Charnsilp, Chawanun; Jarusuraisin, Ngamwong
PUB. DATE
January 2007
SOURCE
BMC Psychiatry;2007, Vol. 7, p14
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Not only the prevalence, but also the progress of metabolic abnormalities in schizophrenic patients is of importance for treatment planning and policy making. However, there have been very few prospective studies of metabolic disturbance in schizophrenic patients. This study aimed to assess the progress of metabolic abnormalities in Thai individuals with schizophrenia by estimating their one-year incidence rate of metabolic syndrome (MetS). Methods: We screened all schizophrenic patients who visited our psychiatric clinic. After the exclusion of participants with MetS at baseline, each subject was reassessed at 6 and 12 months to determine the occurrence of MetS. The definition of MetS, as proposed by the International Diabetes Federation (IDF), was applied. Results: Fifty-seven participants (24 males and 33 females) had a mean of age and duration of antipsychotic treatment of 37.5 years old and 8.4 years, respectively. At baseline, 13 subjects met the MetS definition. Of 44 subjects who had no MetS at baseline, 35 could be followed up. Seven of these 35 subjects (20.0%) had developed MetS at the 6- or 12-month visit, after already having 2 MetS components at baseline. The demographic data and characteristics of those developing and not developing MetS were not different in any respect. Conclusion: Thai schizophrenic patients are likely to develop MetS. Their metabolic abnormalities may progress rapidly and fulfill the MetS definition within a year of follow-up. These findings support the importance of assessing and monitoring metabolic syndrome in schizophrenic patients.
ACCESSION #
29962931

 

Related Articles

  • La incógnita del síndrome metabólico X. Solé-Plans, Sergi // Actas Espanolas de Psiquiatria;Nov-Dic2015, Vol. 43 Issue 6, p237 

    No abstract available.

  • Prevalence of the Metabolic Syndrome in the United States. 2003-2012. Aguilar, Maria; Bhuket, Taft; Torres, Sharon; Liu, Benny; Wong, Robert J. // JAMA: Journal of the American Medical Association;5/19/2015, Vol. 313 Issue 19, p1973 

    A letter to the editor is presented in response to the article, related to prevalence of the Metabolic Syndrome in the U.S., published in previous issues of the journal.

  • Metabolic syndrome and schizophrenia. Thakore, Ogin H. // British Journal of Psychiatry;Jun2005, Vol. 186, p455 

    The article presents the views of the author on the higher frequency of metabolic syndrome among schizophrenics. Metabolic syndrome refers to a cluster of disorders that includes obesity, dyslipidaemia, glucose intolerance, insulin resistance and hypertension. According to the author, chronic...

  • The metabolic syndrome and schizophrenia: A comorbidity or an association? khalil, Rami Bou // Journal of Pharmacology & Pharmacotherapeutics;Jul-Sep2013, Vol. 4 Issue 3, p190 

    The article discusses the connection between the metabolic syndrome and schizophrenia. It states that the lifestyle of patients with schizophrenia is accompanied with the risk factors which may increase the risk of the development of metabolic syndrome. It also mentions that the risk of...

  • COMMENTARY. Smith, Shubulade // Evidence Based Mental Health;May2008, Vol. 11 Issue 2, p62 

    The article comments on the study "Metabolic syndrome among persons with schizophrenia and other psychotic disorders in a general population survey," by J.M. Suvisaari and colleagues. The author notes that the study is a good working knowledge of the metabolic side effects of all antipsychotics...

  • Prevalence of metabolic syndrome and its association with depression in patients with schizophrenia. Sirijit Suttajit; Sutrak Pilakanta // Neuropsychiatric Disease & Treatment;2013, Vol. 9, p941 

    Purpose: To identify the point prevalence of metabolic syndrome in patients with schizophrenia and to evaluate the association between depressive symptoms and metabolic syndrome in patients with schizophrenia. Patients and methods: Metabolic syndrome was assessed based on an updated definition...

  • Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a doubleblind, randomized, open-label study. Wani, Rayees Ahmad; Dar, Mansoor Ahmad; Chandel, Rajesh Kumar; Rather, Yasir Hassan; Haq, Inaamul; Hussain, Arshad; Malla, Altaf Ahmad // Neuropsychiatric Disease & Treatment;2015, Vol. 11, p685 

    Background: Patients with schizophrenia suffer high rates of metabolic derangements on some antipsychotic medications that predispose them to cardiovascular diseases. Keeping this fact in mind, we planned this open-label study to see the effect on various metabolic parameters after switching...

  • Prevalence of diabetes, metabolic syndrome and metabolic abnormalities in schizophrenia over the course of the illness: a cross-sectional study. De Hert, M.; van Winkel, R.; Van Eyck, D.; Hanssens, L.; Wampers, M.; Scheen, A.; Peuskens, J. // Clinical Practice & Epidemiology in Mental Health;2006, Vol. 2, p14 

    Background: Patients with schizophrenia are at high risk of developing metabolic abnormalities. Method: A prospective study focusing on metabolic disturbances in patients with schizophrenia, including an oral glucose tolerance test, is currently ongoing at our University Hospital and affiliate...

  • Metabolic syndrome in schizophrenia: Differences between antipsychotic-naïve and treated patients. Chadda, Rakesh K.; Ramshankar, Prashanth; Deb, Koushik S.; Sood, Mamta\ // Journal of Pharmacology & Pharmacotherapeutics;Jul-Sep2013, Vol. 4 Issue 3, p174 

    Metabolic syndrome (MetS) has been recognized as a risk factor for cardiovascular morbidity and mortality in general population and in patients with severe mental illnesses like schizophrenia. This paper reviews studies on MetS in schizophrenia and related psychotic disorders, and assesses the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics